Photophysics and photobiology of novel liposomal formulations of 2,9(10), 16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II)

Six novel liposomal formulations of 2,9(10),16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II) (Pc9) were investigated to establish how the environments affect their photophysical and photobiological properties. The incorporation efficiency and solubility during a time pe...

Full description

Bibliographic Details
Authors: López Zeballos, Noelia del Carmen, Marino, Veronica Julieta, Garcia Vior, María Cecilia, Chiarante, Nicolás Agustín, Roguin, Leonor Patricia, Awruch, Josefina, Dicelio, Lelia Elina
Format: article
Status:Published version
Publication Date:2013
Country:Argentina
Institution:Consejo Nacional de Investigaciones Científicas y Técnicas
Repository:CONICET Digital (CONICET)
Language:English
OAI Identifier:oai:ri.conicet.gov.ar:11336/16680
Online Access:http://hdl.handle.net/11336/16680
Access Level:Open access
Keyword:Photodynamic Therapy
Phthalocyanine
Singlet Oxygen
Photocytotoxicity
Liposome
Kb Cells
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
Description
Summary:Six novel liposomal formulations of 2,9(10),16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II) (Pc9) were investigated to establish how the environments affect their photophysical and photobiological properties. The incorporation efficiency and solubility during a time period were evaluated. All Pc9-liposomal formulations were efficient singlet oxygen quantum yield generators. The photobiological potentials were evaluated on human nasopharynx KB carcinoma cells. None of the formulations studied showed cytotoxic effects in the absence of light, whereas all of them showed good performance after irradiation. The 50% inhibition of cell proliferation (IC50) was in the range of 0.21–0.47 μM for Pc9-loaded liposome formulations. A lysosomal localization was found for S-PEG as well as for S.